# Jeffrey Lu

> Jeffrey Lu is a startup investor at Engine Biosciences (Singapore). See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Engine Biosciences](https://shizune.co/investors/profile/engine-biosciences)
- Location: Singapore, Singapore
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/jeffrey-lu-47606b18/

Jeffrey Lu is an experienced entrepreneur, corporate executive, and investor in technology and life sciences. He is currently co-founder and CEO of Engine Biosciences, which builds upon novel experimental biology and data science developed previously at MIT, Harvard, Mayo Clinic, and UCSD to decipher biological complexity for breakthrough drugdiscovery and other applications. As a private investor, he has led deals in a large number of early and growth stage companies, serving as board director and/or advisor and resulting in notable IPOs and trade sales. He has previously built two companies towards highly profitable exits at a total combined valuation of US$450M. Earlier in his career, Jeff was a consultant at Bain & Company, where his clients included private equity and large corporates in healthcare, TMT, financial services, and travel, and prior to that he worked at a technology-focused hedge fund. He received his bachelor’s degree summa cum laude from the University of Pennsylvania.

## About Engine Biosciences

VC Fund · San Francisco, United States

Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. The company's proprietary and patented technologies oriented around deciphering the complexity of biology networks includeboth high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications.

3 contacts available at Engine Biosciences.

| Name | Title | Profile |
| --- | --- | --- |
| Jeffrey Lu | Co-Founder and CEO | https://shizune.co/investors/profile/jeffrey-lu-6188 |
| Stephen D Harrison | CSO & SVP | https://shizune.co/investors/profile/stephen-d-harrison |
| Timothy Lu | Co-Founder & Board Member | https://shizune.co/investors/profile/timothy-k-lu |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co